C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2006
08/29/2006	US7098000 Method for production of C30-aldehyde carotenoids
08/29/2006	US7097999 Method for producing target substance using microorganisms with reduced interactions between MalK and IIAGlc
08/29/2006	US7097994 UDP-N-acetylglucosamine:galactose-β1,3-N-acetylgalactosamine-α-R/ (GlcNAc to GaINAc) β1-6 N-acetylglucosaminyltransferase, C2GnT3
08/29/2006	US7097991 screening for an agent that modulates capsaicin receptor function
08/29/2006	US7097990 Method of screening cell death inhibitor
08/29/2006	US7097987 Hepatitis C receptor protein CD81
08/29/2006	US7097986 For use in pharmaceutical and diagnostic formulations
08/29/2006	US7097985 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis
08/29/2006	US7097983 Lateral-flow or immunochromatographic test kits for liquid samples, e.g. pregnancy, milk
08/29/2006	US7097980 Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
08/29/2006	US7097979 Detection of HIV-1 by nucleic acid amplification
08/29/2006	US7097978 Screening methods based on isolating a collection of polynucleotides corresponding to accessible regions of chromatin
08/29/2006	US7097977 Target of anticancer agent
08/29/2006	US7097974 Parallel synthesis of oligomeric building blocks; detaching from the support and bringing them in contact to synthesize DNA; directly converting genetic information into nucleic acids without using nucleic acid fragments already present
08/29/2006	US7097972 invention provides non-naturally occurring and isolated naturally occurring nucleic acid molecules which code proteins designated Yama Pro-Yama and non-naturally occurring nucleic acid molecule coding mutant CrmA protein and dominant inhibitory Yama.Vectors and host cells containing these nucleic acids
08/29/2006	US7097970 Screening for modulators of viral infections; obtain cells, incubate with modulators, transfect cells, evaluate viral infective activity
08/29/2006	US7097969 IDENTIFYING AN ALLOSTERIC MODULATOR/ANTAGONIST OF G-PROTEIN COUPLED RECEPTORS FOR TREATMENT OF METABOLIC DISORDERS and diseases that have been linked to overactive GPCRs, because traditional neutral-antagonists will not block abnormal ligand-independent activity of these receptors
08/29/2006	US7097882 Substrate for immobilizing physiological material, and method of fabricating same
08/29/2006	US7097846 35 kD tumor associated protein antigen: uses and methods of detection
08/29/2006	US7097842 Modified vaccinia virus ankara for the vaccination of neonates
08/29/2006	US7097841 Ferritin fusion proteins for use in vaccines and other applications
08/29/2006	US7097840 Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
08/29/2006	US7097834 Osteoprotegerin binding proteins
08/29/2006	US7097829 Transgenic cells transfected with pituitary tumor transforming gene (PTTG)) expression vectors and uses therefor
08/29/2006	US7097751 Base sequence detecting electrode, base sequence detecting device and base sequence detecting method
08/29/2006	CA2318851C Recombinant human mannan-binding proteins and process for producing the same
08/29/2006	CA2187974C Newcastle disease virus combination vaccine
08/29/2006	CA2176038C Recombinant yeasts for effective fermentation of glucose and xylose
08/29/2006	CA2111238C Production of a protein of interest in the milk of a transgenic mammal
08/29/2006	CA2053585C Antibody production in chinese hamster ovary cells
08/24/2006	WO2006089259A1 Enzymatic digestion of tissue
08/24/2006	WO2006089154A1 Sample preparation method incorporating an alkaline shock
08/24/2006	WO2006089152A2 Use of methyltransferase inhibitors to enhance transgene expression
08/24/2006	WO2006089001A2 Lentiviral vectors and their use
08/24/2006	WO2006088962A2 Replikin peptides and uses thereof
08/24/2006	WO2006088888A2 Aptamer therapeutics useful in the treatment of complement-related disorders
08/24/2006	WO2006088833A2 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
08/24/2006	WO2006088490A2 Oligonucleotides comprising a non-phosphate backbone linkage
08/24/2006	WO2006088325A1 Bacillus sp. i-52, a detergent- and oxidant-stable haloalkalophilic protease therefrom, a gene encoding the same and a use thereof
08/24/2006	WO2006088307A1 Rhodococcus - e. coli shuttle vector
08/24/2006	WO2006088258A1 Cartridge retaining mechanism for nucleic acid extracting apparatus
08/24/2006	WO2006088229A1 Modified virus capsid protein and the use thereof
08/24/2006	WO2006088226A1 Method for determining phospholipidosis
08/24/2006	WO2006088219A1 Il-13 production inhibitor
08/24/2006	WO2006088208A1 Method of estimating physiological change in living body and apparatus tehrefor
08/24/2006	WO2006088198A1 Method of producing protein by using hamster igf-1
08/24/2006	WO2006088165A1 Gene detection reagent and the use thereof
08/24/2006	WO2006088126A1 Gene detection method
08/24/2006	WO2006088110A1 Novel protein promoting carbonic acid fixation and method of fixing carbonic acid by using the protein
08/24/2006	WO2006088030A1 Nucleic acid extraction method, nucleic acid-extracting agent and kit for extracting nucleic acid
08/24/2006	WO2006088010A1 Antimicrobial peptide and use thereof
08/24/2006	WO2006087890A1 Electrode pair noncontact manipulation device and manipulation method
08/24/2006	WO2006087756A2 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity
08/24/2006	WO2006087752A2 Cationic lipids for the transfection of nucleic acids
08/24/2006	WO2006087637A2 Anti her2/neu antibody
08/24/2006	WO2006087576A1 Listeriolysin-containing bacillus spores as antigen delivery agents
08/24/2006	WO2006087539A1 Peptides, nucleic acids and materials
08/24/2006	WO2006087536A1 Compounds
08/24/2006	WO2006087364A1 Plant cyclopropane fatty acid synthase genes and uses thereof
08/24/2006	WO2006087334A1 Use of bacterium strains for the preparation of metallic biocatalysts, in particular for the preparation of palladium biocatalysts
08/24/2006	WO2006087242A2 Intracellular inhibitor peptides and transgenic animals expressing same
08/24/2006	WO2006086870A1 Aprotinin polypeptides for transporting a compound across the blood-brain barrier
08/24/2006	WO2006086838A1 Flavivirus replicon constructs for tumour therapy
08/24/2006	WO2006066925A3 Novel genes involved in gluconeogenesis
08/24/2006	WO2006066588A3 Control sequences responding to amp and uses thereof
08/24/2006	WO2006066054A3 A root-preferred, wound- and insect-inducible 2-oxoglutarate-dependent oxygenase promoter from maize and its use
08/24/2006	WO2006060699A9 Methods of increasing seed yield
08/24/2006	WO2006060314A9 Generation of replication competent viruses for therapeutic use
08/24/2006	WO2006058226A3 Modified dimeric streptavidins and uses thereof
08/24/2006	WO2006056987A3 Leptin antagonists
08/24/2006	WO2006056823A8 Modulating retinal pigmented epithelium permeation by inhibiting or activating vegfr-1
08/24/2006	WO2006055040A3 Identification of proteins in a genome
08/24/2006	WO2006051418A3 Transcription factor of the zn binuclear cluster family of fungal regulators
08/24/2006	WO2006047669A3 Non-random method of gene shuffling
08/24/2006	WO2006047635A3 Methods and compositions for seprase inactivation
08/24/2006	WO2006047495A3 Methods and materials for conferring resistance to pests and pathogens of plants
08/24/2006	WO2006047233A3 Pink-1 promoter
08/24/2006	WO2006046239B1 A thymus-specific protein
08/24/2006	WO2006045103A3 Device and method for removing heavy metals from contaminated samples with membranes comprising purified metallothionein
08/24/2006	WO2006040684A3 Methods for increasing plant growth
08/24/2006	WO2006040330A3 Improved adenoviral vectors and uses thereof
08/24/2006	WO2006039678A3 Establishment of highly metastatic cell lines using nog mice
08/24/2006	WO2006039480A3 Tissue non-specific alkaline phosphate (tnap): a therapeutic target for arterial calcification
08/24/2006	WO2006038128A3 Citrobacter freundii phytase and homologues
08/24/2006	WO2006038035A3 In vitro evolution in microfluidic systems
08/24/2006	WO2006037127A3 Single-stranded antimicrobial oligonucleotides and uses thereof
08/24/2006	WO2006033918A3 Polypeptides for inducing a protective immune response against staphylococcus aureus
08/24/2006	WO2006028576A3 Determination of a phosphorylation site in ppiase domain of pin1 and uses therefor
08/24/2006	WO2006016808A3 Means and methods for producing a stabilized cell of interest
08/24/2006	WO2006013388A3 Materials and methods for modulating signalling by alpha-v integrin molecules
08/24/2006	WO2006004768A3 Immortal cell lines containing non-mitochondrial genetic material within the mitochondria
08/24/2006	WO2005120581A3 Gene therapy for neurometabolic disorders
08/24/2006	WO2005118806A3 METHODS AND COMPOSITIONS INVOLVING MicroRNA
08/24/2006	WO2005113813A3 Nucleic acid ligands specific to immunoglobulin e and their use as atopic disease therapeutics
08/24/2006	WO2005093050A3 Cellulase fusion protein and heterologous cellulase fusion construct encoding the same
08/24/2006	WO2005071090A8 Two-component rna virus-derived plant expression system
08/24/2006	WO2005056830A8 Genetic reference materials
08/24/2006	WO2005030134A3 Relationship of a specific metabolite to insulin resistance
08/24/2006	WO2005027725A3 Determination of ions using ion-sensitive enzymes
08/24/2006	WO2005001031A3 Modulation of the rna interference pathway

1 ... 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 ... 4023